SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1151)11/6/1998 12:35:00 PM
From: Tunica Albuginea  Read Replies (5) | Respond to of 3576
 
Richard, as a long term practicing physician I just love these nice gaps up in all these biotechs. A great opportunity to short these suckers. It is very difficult in the biotech field to bring a viable product to market.For every Amgen there are tens and tens of casualties along the way.
Let's see the price of GERN monday, along with the available float for shorting.Allow the usual 3-day-memory-honeymoon to pass and this sucker will be ripe for picking/shorting.
Let me clarify: All the Kudos to the company for their work.But let us not confuse the scientific value of a company with it's stock price:the two are connected only in the mind of the investor,

TA



To: scaram(o)uche who wrote (1151)11/6/1998 5:11:00 PM
From: Triffin  Respond to of 3576
 
RE: CNBC & Steven Franks..other biotechs
ALXN..NRGN..PGNX mentioned

jim in CT..



To: scaram(o)uche who wrote (1151)11/7/1998 1:23:00 AM
From: freelyhovering  Read Replies (1) | Respond to of 3576
 
Richard--Thanks for your comments Thursday eve. I was able to get my double--1/2 at the opening and the other half on the second rise. A lovely day for a future earner. Myron


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News